Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a
AbstractOcimum plants are traditionally used to manage HIV/AIDS in various African countries. The effects of Ocimum labiatum extract on HIV-1 protease (PR) and reverse transcriptase (RT) is presented here along with characterization of an identified bioactive compound, achieved through 1H- and 13C-NMR. The extract’s effect on HIV-1 replication was assessed by HIV-1 p24 antigen capture. Cytotoxicity of samples was evaluated using tetrazolium dyes and real-time cell electronic sensing (RT-CES). Ocimum labiatum inhibited HIV-1 PR with an IC50 value of 49.8 ± 0.4 μg/mL and presented weak inhibition (21%) against HIV-1 RT. The extract also reduced HIV-1 replication in U1 cells at a non-cytotoxic concentration (25 μg/mL). The CC50 value of the extract in U1 cells was 42.0 ± 0.13 μg/mL. The HIV-1 PR inhibiting fraction was purified using prep-HPLC and yielded a chlorophyll derivative, pheophytin-a (phy-a). Phy-a inhibited HIV-1 PR with an IC50 value of 44.4 ± 1.5 μg/mL (51 ± 1.7 μM). The low cytotoxicity of phy-a in TZM-bl cells was detected by RT-CES and the CC50 value in U1 cells was 51.3 ± 1.0 μg/mL (58.9 ± 1.2 μM). This study provides the first in vitro evidence of anti-HIV activity of O. labiatum and isolated phy-a, supporting further investigation of O. labiatum for lead compounds against HIV-1. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 680 KB)
Share & Cite This Article
Kapewangolo, P.; Kandawa-Schulz, M.; Meyer, D. Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a. Molecules 2017, 22, 1763.
Kapewangolo P, Kandawa-Schulz M, Meyer D. Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a. Molecules. 2017; 22(11):1763.Chicago/Turabian Style
Kapewangolo, Petrina; Kandawa-Schulz, Martha; Meyer, Debra. 2017. "Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a." Molecules 22, no. 11: 1763.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.